• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几种新冠病毒结构蛋白对抗病毒免疫的影响研究

Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity.

作者信息

Yue Rong, Zeng Fengyuan, Ma Danjing, Meng Ziyan, Li Xinghang, Zhang Zhenxiao, Zhang Haobo, Li Qi, Xu Langxi, Niu Zhenye, Li Dandan, Liao Yun, Jiang Guorun, Yu Li, Zhao Heng, Zhang Ying, Liu Longding, Li Qihan

机构信息

Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Kunming 650118, China.

出版信息

Vaccines (Basel). 2023 Feb 23;11(3):524. doi: 10.3390/vaccines11030524.

DOI:10.3390/vaccines11030524
PMID:36992107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10059745/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike (S) protein is a critical viral antigenic protein that enables the production of neutralizing antibodies, while other structural proteins, including the membrane (M), nucleocapsid (N) and envelope (E) proteins, have unclear roles in antiviral immunity. In this study, S1, S2, M, N and E proteins were expressed in 16HBE cells to explore the characteristics of the resultant innate immune response. Furthermore, peripheral blood mononuclear cells (PBMCs) from mice immunized with two doses of inactivated SARS-CoV-2 vaccine or two doses of mRNA vaccine were isolated and stimulated by these five proteins to evaluate the corresponding specific T-cell immune response. In addition, the levels of humoral immunity induced by two-dose inactivated vaccine priming followed by mRNA vaccine boosting, two homologous inactivated vaccine doses and two homologous mRNA vaccine doses in immunized mice were compared. Our results suggested that viral structural proteins can activate the innate immune response and elicit a specific T-cell response in mice immunized with the inactivated vaccine. However, the existence of the specific T-cell response against M, N and E is seemingly insufficient to improve the level of humoral immunity.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突(S)蛋白是一种关键的病毒抗原蛋白,可促使产生中和抗体,而其他结构蛋白,包括膜(M)、核衣壳(N)和包膜(E)蛋白,在抗病毒免疫中的作用尚不清楚。在本研究中,S1、S2、M、N和E蛋白在16HBE细胞中表达,以探索由此产生的固有免疫反应的特征。此外,分离用两剂灭活SARS-CoV-2疫苗或两剂mRNA疫苗免疫的小鼠的外周血单个核细胞(PBMC),并用这五种蛋白进行刺激,以评估相应的特异性T细胞免疫反应。此外,还比较了在免疫小鼠中,两剂灭活疫苗初免后用mRNA疫苗加强、两剂同源灭活疫苗和两剂同源mRNA疫苗诱导的体液免疫水平。我们的结果表明,病毒结构蛋白可激活固有免疫反应,并在接种灭活疫苗的小鼠中引发特异性T细胞反应。然而,针对M、N和E的特异性T细胞反应的存在似乎不足以提高体液免疫水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/260a2215c23b/vaccines-11-00524-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/c6e8287394ac/vaccines-11-00524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/9c6232c047b1/vaccines-11-00524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/afd10addb972/vaccines-11-00524-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/bb0e61c89aec/vaccines-11-00524-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/260a2215c23b/vaccines-11-00524-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/c6e8287394ac/vaccines-11-00524-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/9c6232c047b1/vaccines-11-00524-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/afd10addb972/vaccines-11-00524-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/bb0e61c89aec/vaccines-11-00524-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/10059745/260a2215c23b/vaccines-11-00524-g005.jpg

相似文献

1
Study of the Effects of Several SARS-CoV-2 Structural Proteins on Antiviral Immunity.几种新冠病毒结构蛋白对抗病毒免疫的影响研究
Vaccines (Basel). 2023 Feb 23;11(3):524. doi: 10.3390/vaccines11030524.
2
Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.两剂蛋白亚单位疫苗 MVC-COV1901 初免后加强接种多剂 mRNA 疫苗可增强针对新型 SARS-CoV-2 变异株的体液和细胞免疫应答。
Microbiol Spectr. 2022 Oct 26;10(5):e0060922. doi: 10.1128/spectrum.00609-22. Epub 2022 Aug 25.
3
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
4
Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.接种不同类型和剂量的新型冠状病毒2疫苗后疫苗接种后免疫球蛋白G抗体和T细胞免疫反应的评估:一项回顾性队列研究。
Front Med (Lausanne). 2023 Jan 10;9:1092646. doi: 10.3389/fmed.2022.1092646. eCollection 2022.
5
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.严重急性呼吸综合征疫苗研发:针对禽传染性支气管炎冠状病毒的疫苗接种经验
Avian Pathol. 2003 Dec;32(6):567-82. doi: 10.1080/03079450310001621198.
6
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
7
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.使用病毒刺突蛋白DNA和蛋白质进行初免-加强免疫接种对中东呼吸综合征冠状病毒的交叉保护作用。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01176-20.
8
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.皮下注射紫外线灭活的严重急性呼吸综合征冠状病毒疫苗可在小鼠体内引发全身性体液免疫。
Int Immunol. 2004 Oct;16(10):1423-30. doi: 10.1093/intimm/dxh143. Epub 2004 Aug 16.
9
Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.重组杆状病毒表达的严重急性呼吸综合征冠状病毒刺突蛋白的抗原性和免疫原性特征:对疫苗设计的启示
J Virol. 2006 Jun;80(12):5757-67. doi: 10.1128/JVI.00083-06.
10
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate.在灭活候选疫苗的 SARS-CoV-2 病毒粒子的纯化中,对结构蛋白及其翻译后修饰进行的生化和抗原特性分析。
Emerg Microbes Infect. 2020 Dec;9(1):2653-2662. doi: 10.1080/22221751.2020.1855945.

引用本文的文献

1
Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool.通过稳定的HEK293细胞库快速且可扩展地生产功能性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒(VLPs)
Vaccines (Basel). 2024 May 21;12(6):561. doi: 10.3390/vaccines12060561.
2
Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals.在撒哈拉以南非洲地区,科兴疫苗(Sinovac)接种后可产生持续的刺突特异性 IgG 抗体,但基线刺突抗体阴性的个体突破性感染增加。
Front Immunol. 2023 Nov 30;14:1255676. doi: 10.3389/fimmu.2023.1255676. eCollection 2023.
3

本文引用的文献

1
A perspective on SARS-CoV-2 virus-like particles vaccines.SARS-CoV-2 病毒样颗粒疫苗的展望。
Int Immunopharmacol. 2023 Feb;115:109650. doi: 10.1016/j.intimp.2022.109650. Epub 2023 Jan 11.
2
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines.mRNA 或灭活病毒 COVID-19 疫苗诱导的 SARS-CoV-2 特异性 T 细胞的比较特征。
Cell Rep Med. 2022 Nov 15;3(11):100793. doi: 10.1016/j.xcrm.2022.100793. Epub 2022 Oct 6.
3
Humoral and cellular immune memory to four COVID-19 vaccines.
Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳蛋白(N)的刺突特异性抗体反应在全病毒疫苗中的独立保护作用及影响
Vaccines (Basel). 2023 Nov 2;11(11):1681. doi: 10.3390/vaccines11111681.
体液免疫和细胞免疫对四种 COVID-19 疫苗的记忆。
Cell. 2022 Jul 7;185(14):2434-2451.e17. doi: 10.1016/j.cell.2022.05.022. Epub 2022 May 27.
4
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)特异性 T 细胞和抗体在 2019 年冠状病毒病(COVID-19)保护中的作用:一项前瞻性研究。
Clin Infect Dis. 2022 Aug 24;75(1):e1-e9. doi: 10.1093/cid/ciac278.
5
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants.一种多表位 SARS-CoV-2 疫苗可提供针对 Delta 和奥密克戎变异株的持久 B 细胞和 T 细胞免疫。
J Clin Invest. 2022 May 16;132(10). doi: 10.1172/JCI157707.
6
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
7
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.用于 COVID-19 预防和治疗的 SARS-CoV-2 中和抗体。
Annu Rev Med. 2022 Jan 27;73:1-16. doi: 10.1146/annurev-med-042420-113838. Epub 2021 Aug 24.
8
The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation.新型冠状病毒核衣壳蛋白及其在病毒结构、生物学功能中的作用,以及作为药物或疫苗缓解的潜在靶点。
Viruses. 2021 Jun 10;13(6):1115. doi: 10.3390/v13061115.
9
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的固有免疫和炎症反应:对冠状病毒病(COVID-19)的影响
Cell Host Microbe. 2021 Jul 14;29(7):1052-1062. doi: 10.1016/j.chom.2021.05.004. Epub 2021 May 17.
10
TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines.Toll样受体2(TLR2)可识别严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的包膜蛋白以产生炎性细胞因子。
Nat Immunol. 2021 Jul;22(7):829-838. doi: 10.1038/s41590-021-00937-x. Epub 2021 May 7.